Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563714 · ClinicalTrials.gov registry record · NA
Anticoagulation With Enhanced Gastrointestinal Safety
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 341
- Enrollment target
NCT05563714 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 341 participants.
The verdict
NCT05563714, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 341 participants
- Enrollment target
Study Summary
This study is a pragmatic cluster randomized controlled trial to evaluate the effectiveness of a clinician-facing implementation strategy on the use of medication optimization (defined as either discontinuation of all antiplatelet therapy or initiation of and adherence to a proton pump inhibitor (PPI)) to reduce upper GI bleeding risk in patients prescribed anticoagulant-antiplatelet therapy (AAT) relative to usual care.
Interventions
- BEHAVIORAL Clinician Notification with Nurse Facilitation (CNNF)
- BEHAVIORAL Wait list control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2023-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05563714
The ClinicalTrials.gov registry entry for NCT05563714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 341 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clinician Notification with Nurse Facilitation (CNNF) is the first listed.
NCT05563714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05563714 about?
NCT05563714 is a clinical study titled "Anticoagulation With Enhanced Gastrointestinal Safety". This study is a pragmatic cluster randomized controlled trial to evaluate the effectiveness of a clinician-facing implementation strategy on the use of medication optimization (defined as either discontinuation of all antiplatelet therapy or initiation of and adherence to a proton pump inhibitor (PP...
What is the current status of trial NCT05563714?
This trial is currently completed. It is a NA study. The enrollment target is 341 participants. The study started on 2022-10-05. Estimated completion is 2023-01-04.
What interventions are being tested in trial NCT05563714?
The interventions under investigation include: Clinician Notification with Nurse Facilitation (CNNF) (BEHAVIORAL), Wait list control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05563714?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.